Simcor contains simvastatin and niacin. Simvastatin is metabolized by CYP3A4, and niacin is able to inhibit this isoform. Is niacin a strong or weak CYP3A4 inhibitor? Can niacin alter simvastatin pharmacokinetics?
I think this paper (maybe not exactly the case of Simcor) concludes the situation very well:
"There is a small pharmacokinetic drug interaction between ER niacin and ezetimibe/simvastatin and although this is not considered to be clinically significant, the concomitant use of these drugs should be appropriately monitored, especially during the niacin titration period."
Article Assessment of potential pharmacokinetic interactions of ezet...